ArticleAnnals of operations research2022
Robust optimization model of anti-epidemic supply chain under technological innovation: learning from COVID-19.
Article in Annals of operations research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The anti-epidemic supply chain plays an important role in the prevention and control of the COVID-19 pandemic. Prior research has focused on studying the facility location, inventory management, and route optimization of the supply chain by using certain parameters and models. Nevertheless, uncertainty, as a vital influence factor, greatly affects the supply chain. As such, the uncertainty that comes with technological innovation has a heightened influence on the supply chain. Few studies have explicitly investigated the influence of technological innovation on the anti-epidemic supply chain under the COVID-19 pandemic. Hence, the current research aims to investigate the influences of the uncertainty caused by technological innovation on the supply chain from demand and supply, shortage penalty, and budget. This paper presents a three-level model of the anti-epidemic supply chain under technological innovation and employs an interval data robust optimization to tackle the uncertainties of the model. The findings are obtained as follows. Firstly, the shortage penalty will increase the costs of the objective function but effectively improve demand satisfaction. Secondly, if the shortage penalty is sufficiently large, the minimum demand satisfaction rate can ensure a fair distribution of materials among the affected areas. Thirdly, technological innovation can reduce costs. The technological innovation related to the transportation costs of the anti-epidemic material distribution center has a greater influence on the optimal value. Meanwhile, the technological innovation related to the transportation costs of the supplier has the least influence. Fourthly, both supply and demand uncertainty can influence costs, but demand uncertainty has a greater influence. Fifthly, the multi-scenario budgeting approach can decrease the calculation complexity. These findings provide theoretical support for anti-epidemic dispatchers to adjust the conservativeness of uncertain parameters under the influence of technological innovation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.